VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

MDS 2020 | Introducing tauopathies and movement disorders

Adam Boxer • 9 Sep 2020
MDS 2020
Movement Disorders
Biology

Adam Boxer, MD, PhD, UCSF Weill Institute for Neurosciences, San Francisco, CA, introduces tauopathies and explains the role of the protein tau in a range of movement disorders. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Adam Boxer

8:08
Promising advanced tau therapies for movement disorders
Adam Boxer • 9 Sep 2020
2:00
The 4 Repeat Tauopathy Neuroimaging Initiative
Adam Boxer • 9 Sep 2020
1:23
The future of tau therapies for movement disorders
Adam Boxer • 9 Sep 2020

Related Videos

1:42
The importance of partnerships between healthcare professionals and Parkinson’s disease patients
Alfonso Fasano • 7 Sep 2023
17:52
Neuromodulation of freezing in Parkinson's disease
Alfonso Fasano • 7 Sep 2023
2:08
The future of neuromodulation in movement disorders
Alfonso Fasano • 7 Sep 2023
3:08
Levodopa-carbidopa intestinal gel in multiple system atrophy
Andreia Ferreira • 29 Aug 2023
The content of VJNeurology is intended for healthcare professionals